Pharmacokinetic comparison of efanesoctocog alfa vs other EHL-rFVIII products in participants with severe haemophilia A

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-505801-17-00

Acronym

Sobi.BIVV001-003

Enrollment

Registered

2024-04-03

Start date

2025-01-15

Completion date

Unknown

Last updated

2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemophilia A

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Bulgaria, Germany, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026